3231-3240 of 4478 results

CAMAC's 2014 discussion paper on managed investment schemes
Insight 21 Mar 2014

The Corporations and Markets Advisory Committees discussion paper about the establishment and operation of managed investment schemes particularly examines governance disclosure and regulatory issues If the changes are implemented it could profoundly affect these schemes Partners Marc Kemp and Penny ...

Improving the role of the Appointed Actuary
Insight 06 Sep 2016

APRA is seeking to improve the role of the Appointed Actuary in general and life insurance companies and has proposed some reforms in a discussion paper released earlier this year ...

The High Court has its say on penalties
Insight 09 Aug 2016

The high court handed down its decision in Paciocco v Australia and New Zealand banking group limited. ...

Productivity Commission report into superannuation system bodes well for the future
Insight 06 Sep 2016

At first glance the recent Productivity Commission Draft Report on How to Assess the Competitiveness and Efficiency of the Superannuation System August 2016 could be dismissed as nothing more than a procedural step along the road to the ultimate goal as recommended by the FSI of developing an ...

Beware the risks of converting casuals to permanent employees
Insight 16 Aug 2016

A Full Bench of the Fair Work Commission has ruled that prior service as a casual counts as service when calculating redundancy pay The decision is completely at odds with what employers would expect Partner Simon Dewberry Managing Associate Andrew Stirling and Senior Associate Tristan Garcia ...

What's in a (biosimilar) name?
Insight 08 Sep 2016

Because biosimilars and their reference biologic medicine are not identical whether compared to each other or even between biosimilars it is important to know which product has been used ...

Protecting investment in biologic medicines - biological medicines, biosimilars and the challenges they pose
Insight 15 Sep 2016

This series of articles is directed towards the part of biotech that is pharmaceutical rather than diagnostic or bioengineering technologies and in particular towards biologic medicines ...

Protecting accrued superannuation benefits from adverse changes
Insight 06 Sep 2016

For a long time now superannuation lawyers have tried to work out the meaning of the following words a beneficiarys right or claim to accrued benefits and the amount of those accrued benefits must not be altered adversely to the beneficiary by amendment of the governing rules or by any other act ...

Not better late - the Prime Trust appeal judgment
Insight 06 Sep 2016

The main Prime Trust appeal judgement is relatively well known but a trusts responsible entities and their officers should look at what the appeal court had to say on other related matters ...

Competition news
Insight 26 Jun 2017

In Touch looks at whats been happening in Competition this month and what it means for your business ...

Refine